These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2947700)

  • 1. [Determination of C-reactive protein in human serum].
    Votruba T; Hrudková M; Rákosnik P
    Cesk Epidemiol Mikrobiol Imunol; 1986 Nov; 35(6):321-8. PubMed ID: 2947700
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quantitative determination of C-reactive protein using the microturbidimetry method].
    Vacková I; Bouzek J; Kvasnicka J
    Cas Lek Cesk; 1991 Feb; 130(8):249-52. PubMed ID: 2025898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nephelometry or turbidimetry for the determination of albumin, ApoA, CRP, haptoglobin, IgM and transthyretin: which choice?].
    Thuillier F; Demarquilly C; Szymanowicz A; Gaillard C; Boniface M; Braidy C; Daunizeau A; Gascht D; Gruson A; Lagabrielle JF; Lasnier E; Lemdani M; Macchi V; Poulin G; de Sainte Hermine C; Sancho J; Schellenberg F; Sevin O; Vaubourdolle M;
    Ann Biol Clin (Paris); 2008; 66(1):63-78. PubMed ID: 18227006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Turbidimetric determination of C-reactive protein].
    Borte M; Pöge A; Braun W
    Z Med Lab Diagn; 1990; 31(8):453. PubMed ID: 2095061
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation and comparison of two immunoturbidimetric assays for the heterologous determination of porcine serum C-reactive protein.
    Kjelgaard-Hansen M; Martínez-Subiela S; Petersen HH; Jensen AL; Ceron JJ
    Vet J; 2007 May; 173(3):571-7. PubMed ID: 16546421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rheumatoid factors, C-reactive protein and circulating immunocomplexes: laser-nephelometric determination using the latex aggregation method. Preliminary evaluation in rheumatoid arthritis].
    Bartoloni C; Guidi L; Tricerri A; Baroni R; Pellegrino M; Scrimieri D; Gambassi G
    Minerva Med; 1987 Dec; 78(23):1775-8. PubMed ID: 3696453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of high-sensitivity C-reactive protein serum assay results obtained using Dade-Behring BNII nephelometer and Ortho Vitros FS 5.1 clinical analyzer in respect of CRP-related risk assessment of chronic metabolic diseases.
    Kusnierz-Cabala B; Gernand W; Zabek-Adamska A; Tokarz A; Naskalski JW
    Clin Lab; 2008; 54(9-10):341-6. PubMed ID: 19097491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis.
    Conrozier T; Chappuis-Cellier C; Richard M; Mathieu P; Richard S; Vignon E
    Rev Rhum Engl Ed; 1998 Dec; 65(12):759-65. PubMed ID: 9923044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory assessment of the acute phase response: using CRP as a model.
    Ritchie RF; Ledue TB
    Methods Mol Biol; 2003; 225():343-52. PubMed ID: 12769501
    [No Abstract]   [Full Text] [Related]  

  • 10. Analytical evaluation of a new latex agglutination test for quantitative determination of C-reactive protein by laser nephelometry.
    Adam A; Ers P; Herman G; Stas JL
    J Clin Chem Clin Biochem; 1985 Nov; 23(11):787-9. PubMed ID: 4086983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three immunoassays for C-reactive protein determination.
    Mackiewicz A; Wiktorowicz K; Mackiewicz S
    Arch Immunol Ther Exp (Warsz); 1985; 33(5):693-701. PubMed ID: 3938944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Particle enhanced immunoturbidimetic assay of high sensitive C-reactive protein].
    Hu M; Li YW; Hu YH
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):415-7. PubMed ID: 14653135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HS CRP with Fumouze immunoturbidimetry and Dade Behring immunonephelemetry].
    Onraed B; Hennache B
    Ann Biol Clin (Paris); 2005; 63(3):339-44. PubMed ID: 15951269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 3 automated assays for C-reactive protein in end-stage renal disease: clinical and epidemiological implications.
    Maggiore U; Cristol JP; Canaud B; Dupuy AM; Formica M; Pozzato M; Panichi V; Consani C; Metelli MR; Sereni L; De Nitti C; David S; Tetta C
    J Lab Clin Med; 2005 Jun; 145(6):305-8. PubMed ID: 15976758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre evaluation of performance of C-reactive protein analysis over a one-year period.
    Bewarder N; Abmeier F; Bergmann S; Drohla S; Drescher V; Gerstmeyer A; Kuss S; Melamies L; Miksch R; Ortin V; Rietschel-Klein A; Neumeister V; Odarjuk J; Stratmann MM; Weinhold A; Wiesner B; Wildbredt DA; Wollenberg P; Zinsmeyer J; Zogbaum M; Zwerenz P; Zwirner M; Wood WG
    Clin Lab; 2006; 52(11-12):639-54. PubMed ID: 17175896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of maternal serum high-sensitive C-reactive protein levels with biochemical and clinical parameters in preeclampsia.
    Kumru S; Godekmerdan A; Kutlu S; Ozcan Z
    Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):164-7. PubMed ID: 16054746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of high sensitivity C-reactive protein in coronary artery disease risk prediction: a review.
    Abou Diwan CH; Oghlakian GO; Antonios SI; Otrock ZK; Rebeiz AG
    J Med Liban; 2004; 52(1):39-47. PubMed ID: 15881701
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical value of nephelometric assay of C-reactive protein].
    Audhuy B; Aby MA; Attali P; Pinget M; Dorner M
    Sem Hop; 1983 Jan; 59(1):49-52. PubMed ID: 6297088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a quick test for C-reactive protein in a pediatric emergency department.
    Papaevangelou V; Papassotiriou I; Sakou I; Ferentinos G; Liapi G; Kyrka A; Konstantopoulos A
    Scand J Clin Lab Invest; 2006; 66(8):717-21. PubMed ID: 17101564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of high sensitivity C-reactive protein in assessing the risk for coronary heart disease.
    Legrys VA
    Clin Lab Sci; 2001; 14(4):243-6. PubMed ID: 11760822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.